Industry / India
GSKCH Looks To Match Pharma Division
February 2008 | Company News AlertUK firm GlaxoSmithKline's Indian over-the-counter (OTC) subsidiary, GlaxoSmithKline Consumer Healthcare (GSKCH), is seeking to emulate its compatriot pharmaceutical division and record double-digit growth over the next few years. It hopes to achieve this goal by implementing a three-pronged strategy involving brand development, which is becoming increasingly important in India's maturing economy. BMI believes that GSKCH is well placed to outperform the market by leveraging its highly respected corporate identity.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
